The biopsy needle is a kind of medical equipment, which is used to sample and draw cells from pyramidal tumors and unknown tumors in various organs such as kidney, liver, lung, breast, thyroid, prostate, pancreas, testis, uterus, ovary, body surface, etc.
Due to the COVID-19 pandemic, the global Aspiration & Biopsy Needle market size is estimated to be worth US$ 918.3 million in 2021 and is forecast to a readjusted size of US$ 1573.4 million by 2028 with a CAGR of 7.9% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Aspiration & Biopsy Needle market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Aspiration & Biopsy Needle landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Needle and biopsy needles are mainly divided into vacuum assisted biopsy (VAB), fine needle aspiration biopsy (FNAB) and core needle biopsy (CNB). Among them, core needle biopsy (CNB) accounts for the main part, accounting for about 47% of the total market in 2019.
The sales channels of puncture and biopsy needles are mainly hospitals, clinics and others. Among them, hospitals account for the main part. In 2019, hospitals accounted for about 74.3% of the total market.
North America is the world's main consumer region, and sales in 2019 accounted for 35.2% of the global total. Europe is also a major consumption area, accounting for 30.46% of the global market, and China is also a very important consumption area.
At present, products produced by BD, Mammotome, Medtronic, Hologic, Merit Medical Systems, etc. occupy a major position in the global market.
This report focuses on Aspiration & Biopsy Needle volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Aspiration & Biopsy Needle market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Aspiration & Biopsy Needle Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Fine Needle Aspiration Biopsy (FNAB)
Core Needle Biopsy (CNB)
Vacuum Assisted Biopsy (VAB)
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
BD
Mammotome
Medtronic
Hologic
Merit Medical Systems
Cook
Boston Scientific
Argon Medical Devices
Olympus
ConMed
INRAD
Micro-Tech Endoscopy
Shanghai Kindly Enterprise Development Group Co., Ltd